🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of Melphal...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2018-01-02
Trial ID
NCT03385096
Treatments Being Tested
The involvement of the central nervous system (CNS) by non-Hodgkin lymphoma...
Status
Terminated
Location
Seoul National University Hospital
Start Date
2015-06-01
Trial ID
NCT06625359
Treatments Being Tested
This is a non-randomized, open-label, single-dose study. The aim of this st...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2024-01-04
Trial ID
NCT06219239
Treatments Being Tested
Relapse remains a principle cause of treatment failure for patients with ag...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-08
Trial ID
NCT01181271
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of BUCY+VP...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2017-07-05
Trial ID
NCT03229616
Treatments Being Tested
Autologous hematopoietic stem cell transplantation (Auto-HSCT) is an effect...
Status
Completed
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2016-01
Trial ID
NCT02671708
Treatments Being Tested
This is a standard of care treatment guideline for high risk or relapsed so...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-10-20
Trial ID
NCT01505569
This phase II trial studies how well panobinostat, gemcitabine hydrochlorid...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-09-14
Trial ID
NCT02506959
The current standard of care for the frontline treatment of peripheral T-ce...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2013-07
Trial ID
NCT01746173
The purpose of this study is to evaluate the safety and efficacy of BUCYE c...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2018-11
Trial ID
NCT03733327
Treatments Being Tested